中国实用眼科杂志
中國實用眼科雜誌
중국실용안과잡지
CHINESE JOURNAL OF PRACTICAL OPHTHALMOLOGY
2008年
9期
1000-1002
,共3页
鼻泪管阻塞%泪道探通%先天性
鼻淚管阻塞%淚道探通%先天性
비루관조새%루도탐통%선천성
Nasolacrimal duct obstruction%lacrimal duct probing%Congenital
目的 探讨先天性鼻泪管阻塞的不同治疗方法和治疗时机.方法 回顾分析了735例837只眼在复旦大学附属儿科医院诊断为先天性鼻泪管阻塞的患儿,平均首诊年龄4.5月.根据首诊年龄和症状分别采用保守治疗、加压泪道冲洗法和泪道探通法,经随访3~16月,平均6.4月.以溢泪症状完全消失作为治愈指标.结果 保守治疗的有效率为14.7%;加压泪道冲洗法的有效率为25.4%;泪道探通法的有效率为97.2%;15只眼未愈.早期探通(<6月龄组)1次成功率为87.7%;后期探通(>7月龄组)1次成功率为56.6%.结论 泪道探通法治疗先天性鼻泪管阻寒安全有效,最佳干预时机为4~6月龄.
目的 探討先天性鼻淚管阻塞的不同治療方法和治療時機.方法 迴顧分析瞭735例837隻眼在複旦大學附屬兒科醫院診斷為先天性鼻淚管阻塞的患兒,平均首診年齡4.5月.根據首診年齡和癥狀分彆採用保守治療、加壓淚道遲洗法和淚道探通法,經隨訪3~16月,平均6.4月.以溢淚癥狀完全消失作為治愈指標.結果 保守治療的有效率為14.7%;加壓淚道遲洗法的有效率為25.4%;淚道探通法的有效率為97.2%;15隻眼未愈.早期探通(<6月齡組)1次成功率為87.7%;後期探通(>7月齡組)1次成功率為56.6%.結論 淚道探通法治療先天性鼻淚管阻寒安全有效,最佳榦預時機為4~6月齡.
목적 탐토선천성비루관조새적불동치료방법화치료시궤.방법 회고분석료735례837지안재복단대학부속인과의원진단위선천성비루관조새적환인,평균수진년령4.5월.근거수진년령화증상분별채용보수치료、가압루도충세법화루도탐통법,경수방3~16월,평균6.4월.이일루증상완전소실작위치유지표.결과 보수치료적유효솔위14.7%;가압루도충세법적유효솔위25.4%;루도탐통법적유효솔위97.2%;15지안미유.조기탐통(<6월령조)1차성공솔위87.7%;후기탐통(>7월령조)1차성공솔위56.6%.결론 루도탐통법치료선천성비루관조한안전유효,최가간예시궤위4~6월령.
Objective To evaluate different methods and timing in out patient treatment of congenital nasolacrimal duct obstruction(CNLDO).Methods In the retrospective study,735 infant (837eyes)who were diagnosed as CNLDO in Children's Hospital of Fudan University were involved, the mean age at first examina- tion was 4.5 months.According to age and symptoms,patients were treated with conservative treatment, high-pressure irrigation or nasolacrimal duct probing.All patients wore followed up at least 3~16 months, the mean time was 6.5 months. Clinical success was defined as complete resolution of epiphora.Results The suc- cess rate of this three treatments was 14.7%,25.4% ,97.2% and 15 eyes wore failure.And the success rate with one time probing in the early probing group was 87.7% (<6 months)vs.56.6%in the late probing group (>7 months). Conclusion Nasolacrimal duct probing is a safe and effective method in CNLDO treatment.Also, our dates show that optimal intervention time is 4~6 months.